Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

23.54
Delayed Data
As of Aug 18
 +0.11 / +0.47%
Today’s Change
11.40
Today|||52-Week Range
37.69
+32.77%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close23.43
Today’s open23.20
Day’s range23.20 - 23.54
Volume16,194
Average volume (3 months)29,447
Market cap$199.9M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+43.88%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.93
Price/Book4.01

Competitors

 Today’s
change
Today’s
% change
ABUSArbutus Biopharma Co...0.000.00%
MDGLMadrigal Pharmaceuti...+0.13+0.83%
CKPTCheckpoint Therapeut...-0.25-3.03%
IMDZImmune Design Corp-0.20-2.45%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateAugust 21, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$11.4M
Annual profit (last year)-$16.4M
Net profit margin-143.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ron Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts